CEO: | Paul Carmelo Pagano |
Chief Finance Officer: | David Mark Anderson |
Non-Executive Chairman: | Gordon Roy Davis |
Senior Independent Non-Executive Director: | Andrew Norman Boteler |
Non-Executive Dir: | Sara Barrington |
Address: | 850 New Burton Road, Suite 201, Dover, Delaware, USA, 19904 |
Website: | https://www.lunglifeai.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
Domestic Listings: | LSE:LLA |
ISIN: | USU5500L1045 |
Currency | UK Pounds |
Share Price | 3.00p |
Change Today | 2.10p |
% Change | 233.33 % |
52 Week High | 31.00p |
52 Week Low | 0.90p |
Volume | 9,565,459 |
Shares Issued | 25.49m |
Market Cap | £0.76m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 31,855 @ 2.65p |
15:59 | 2,000 @ 3.23p |
15:35 | 139,701 @ 3.00p |
15:13 | 103,327 @ 2.90p |
15:11 | 7,967 @ 2.90p |
You are here: research